98%
921
2 minutes
20
In recent years, analytical chemistry has been facing new challenges, particularly in developing low-cost, green, and easy-to-reproduce methods. In this work, a simple, reproducible, and low-cost electrochemical (voltammetric) molecularly imprinted polymer (MIP) sensor was designed specifically for the detection of trazodone (TZD). Trazodone (TZD) is an antidepressant drug consumed worldwide since the 1970s. By combining electropolymerization (surface imprinting) with screen-printed electrodes (SPCEs), the sensor is easy to prepare, is environmentally friendly (uses small amounts of reagents), and can be used for in situ analysis through integration with small, portable devices. The MIP was obtained using cyclic voltammetry (CV), using 4-aminobenzoic acid (4-ABA) as the functional monomer in the presence of TZF molecules in 0.1 M HCl. Non-imprinted control was also constructed in the absence of TZD. Both polymers were characterized using CV, and TZD detection was performed with DPV using the oxidation of TZD. The polymerization conditions were studied and optimized. Comparing the TZD signal for MIP/SPCE and NIP/SPCE, an imprinting factor of 71 was estimated, indicating successful imprinting of the TZD molecules within the polymeric matrix. The analytical response was linear in the range of 5-80 µM, and an LOD of 1.6 µM was estimated. Selectivity was evaluated by testing the sensor for molecules with a similar structure to TZD, and the ability of MIP/SPCE to selectively bind to TZD was proven. The sensor was applied to spiked tap water samples and human serum with good recoveries and allowed for a fast analysis (around 30 min).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003412 | PMC |
http://dx.doi.org/10.3390/s22072819 | DOI Listing |
Future Med Chem
August 2025
Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India.
Background: In our continued efforts to explore newer inhibitors for AG to treat T2DM, we report the design and synthesis of a new library of VD-TZD hybrids employing a flexible and efficient synthetic approach for structural modification.
Materials & Methods: Physicochemical, SC-XRD, and spectral analyses were performed to characterize the synthesized compounds and evaluate their AG inhibitory activity.
Results: Compared to Acarbose, VD-TZD hybrids displayed good AGI activity.
J Alzheimers Dis
August 2025
Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & Systems Pharmacology (PSP) PharmacoAnalytics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
BackgroundSeveral hypotheses suggest that type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's disease (AD), and antidiabetic medications may influence cognitive function in these patients.ObjectiveThis study aims to provide a comprehensive evaluation of the impact of single and combination antidiabetic therapies on cognitive function in patients with both AD and T2DM.MethodsWe analyzed data from the National Alzheimer's Coordinating Center (NACC), covering a 17-year period from June 2005 to August 2022.
View Article and Find Full Text PDFBioorg Chem
August 2025
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, 34093 Istanbul, Türkiye. Electronic address:
In this study, a novel series of eleven 3,5-disubstituted thiazolidine-2,4-dione (TZD) derivatives were rationally designed and synthesized, incorporating tertiary amine moieties to enhance cholinesterase binding. The acetamide-linked TZD scaffold was selected for its potential dual functionality: cholinesterase inhibition and cytotoxicity against neuronal cells. All compounds were evaluated for their inhibitory activities against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), alongside cytotoxicity assays on SH-SY5Y cancerous neuroblastoma and HEK-293 healthy cells.
View Article and Find Full Text PDFAlzheimers Dement
August 2025
Department of Pharmacy, Buddhist Tzu Chi Medical Foundation Hualien Tzu Chi Hospital, Hualien City, Taiwan.
Introduction: This study examined the association between metformin-based oral antihyperglycemic combination therapy and the risk of developing dementia in patients with newly diagnosed type 2 diabetes mellitus (T2DM).
Methods: We conducted a retrospective cohort study using data from a random sample of 2,000,000 individuals in Taiwan's National Health Insurance Research Database from 2000 to 2018. A total of 44,073 patients with newly diagnosed T2DM were identified and categorized into four groups based on initial treatment: metformin (MET)-sulfonylureas (SU), MET-dipeptidyl peptidase-4 inhibitor (DPP4i), MET-thiazolidinedione (TZD), and MET-glinides.
J Tradit Chin Med
August 2025
National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Objective: To evaluate the clinical efficacy and safety of Tuomin Zhiti decoction (, TZD) in the short-term treatment of seasonal allergic rhinitis (SAR).
Methods: This study is a randomized, double-blind placebo-controlled, and single-center clinical trial. In April 2021, during the spring pollen season in Beijing, 94 SAR patients aged 19-60 years were randomized (1:1 ratio) to receive two weeks of TZD or placebo.